Skip to content

Member

Christophe CLERGEAU

S&D · France

Group
S&D
Country
France
Roll-call participation
84.6 %ⓘ of 5 928 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line
92.7 %ⓘ of 5 015 votes where the group had a line · S&D median 96.3 %
More facts (5)
National party
PS Parti socialiste
In office
Since 16 Jul 2024
Against clear line
325 of 4 929 votesⓘ
Committees
DEVE (substitute), ENVI, ITRE (substitute), SANT
Member id
245018
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

84.6 %

5 017 of 5 928 roll calls while in office

S&D median: 89.9 % (−5.2 pts)

Chamber median: 90.2 %

With majority line ⓘ

92.7 %

4 648 of 5 015 votes where their group had a line

S&D median: 96.3 % (−3.6 pts)

Against clear line ⓘ

6.6 %

325 of 4 929 votes where their group had a clear line

255 opposite (for ↔ against), 57 abstained against the line, 13 voted for or against when the line was to abstain

Abstention ⓘ

2.4 %

119 of 5 017 votes cast

Participation 84.6 % — S&D median 89.9 %, 138 members.ⓘ
Data as a table
Participation among the 138 members of the S&D with enough votes.
FigureParticipation
Christophe CLERGEAU84.6 %
S&D median89.9 %
Lowest in the group30.4 %
Highest in the group99.6 %
Members138
With majority line 92.7 % — S&D median 96.3 %, 138 members.ⓘ
Data as a table
With majority line among the 138 members of the S&D with enough votes.
FigureWith majority line
Christophe CLERGEAU92.7 %
S&D median96.3 %
Lowest in the group81.9 %
Highest in the group99.4 %
Members138
  • Whole term, 5 928 roll-call votes. The dots are the other members of S&D; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
6 May 2025Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2024/003 BE/Van Hool – Belgium Passed 598 for, 48 against, 5 abstainedPosition: For Majority line: For
6 May 2025Protection of the European Union’s financial interests – combating fraud – annual report 2023 Adopted 473 for, 59 against, 114 abstainedPosition: For Majority line: For
6 May 2025Control of the financial activities of the European Investment Bank – annual report 2023 Adopted 340 for, 162 against, 150 abstainedPosition: Against Majority line: Against
3 Apr 2025Establishing an EU talent pool Negotiating mandate approved 327 for, 229 against, 50 abstainedPosition: No vote recorded Majority line: For
3 Apr 2025Granting equivalence with EU requirements to Moldova and Ukraine as regards field inspections and production of seed Negotiating mandate approved 411 for, 191 against, 13 abstainedPosition: For Majority line: For
3 Apr 2025Amending Directives (EU) 2022/2464 and (EU) 2024/1760 as regards the dates from which Member States are to apply certain corporate sustainability reporting and due diligence requirements Passed 531 for, 69 against, 17 abstainedPosition: For Majority line: For
3 Apr 2025Estimates of revenue and expenditure for the financial year 2026 – Section I – European Parliament Adopted 432 for, 127 against, 54 abstainedPosition: For Majority line: For
3 Apr 2025Immediate risk of further repression by Lukashenka’s regime in Belarus - threats from the Investigative Committee Adopted 535 for, 19 against, 55 abstainedPosition: For Majority line: For
2 Apr 2025Strengthening the security of identity cards of Union citizens and of residence documents issued to Union citizens and their family members exercising their right of free movement Passed 377 for, 279 against, 16 abstainedPosition: For Majority line: For
2 Apr 2025Agreements on Financial Mechanisms for the period May 2021 - April 2028 (EEA: EU-Iceland-Liechtenstein-Norway; Norwegian: EU-Norway); Additional Protocols to EEC-Norway Agreement and to EEC-Iceland Agreement Consent given 528 for, 121 against, 32 abstainedPosition: For Majority line: For
2 Apr 2025Protocol on the Implementation of the Fisheries Partnership Agreement between the European Community and the Republic of Guinea-Bissau (2024-2029) Consent given 518 for, 104 against, 61 abstainedPosition: For Majority line: For
2 Apr 2025EU-Bosnia and Herzegovina Agreement: cooperation between Eurojust and the authorities of Bosnia and Herzegovina competent for judicial cooperation in criminal matters Consent given 619 for, 9 against, 45 abstainedPosition: No vote recorded Majority line: For
2 Apr 2025Guidelines for the 2026 budget – Section III Adopted 441 for, 173 against, 70 abstainedPosition: For Majority line: For
2 Apr 2025Protocol on the Implementation of the Fisheries Partnership Agreement between the European Community and the Republic of Guinea-Bissau (2024-2029) (Resolution) Adopted 605 for, 68 against, 10 abstainedPosition: For Majority line: For
2 Apr 2025Implementation of the common foreign and security policy – annual report 2024 Adopted 378 for, 188 against, 105 abstainedPosition: For Majority line: For
2 Apr 2025Implementation of the common security and defence policy – annual report 2024 Adopted 399 for, 198 against, 71 abstainedPosition: For Majority line: For
2 Apr 2025Human rights and democracy in the world and the European Union’s policy on the matter – annual report 2024 Adopted 390 for, 116 against, 126 abstainedPosition: For Majority line: For
1 Apr 2025Amending Directives (EU) 2022/2464 and (EU) 2024/1760 as regards the dates from which Member States are to apply certain corporate sustainability reporting and due diligence requirements Urgent procedure agreed 427 for, 221 against, 14 abstainedPosition: Against Majority line: Against
1 Apr 2025Common data platform on chemicals, establishing a monitoring and outlook framework for chemicals Passed 481 for, 170 against, 22 abstainedPosition: For Majority line: For
1 Apr 2025Re-attribution of scientific and technical tasks to the European Chemicals Agency Passed 482 for, 110 against, 81 abstainedPosition: For Majority line: For
1 Apr 2025Re-attribution of scientific and technical tasks and improving cooperation among Union agencies in the area of chemicals Passed 486 for, 171 against, 18 abstainedPosition: For Majority line: For
1 Apr 2025Macro-financial assistance to Jordan Passed 571 for, 59 against, 46 abstainedPosition: For Majority line: For
1 Apr 2025Macro-financial assistance to Egypt Passed 452 for, 182 against, 40 abstainedPosition: Abstained Majority line: Against
1 Apr 2025Customs duties on imports of certain products originating in the USA Passed 593 for, 7 against, 35 abstainedPosition: For Majority line: For
13 Mar 2025Democracy and human rights in Thailand, notably the lese-majesty law and the deportation of Uyghur refugees Adopted 482 for, 57 against, 68 abstainedPosition: For Majority line: For
13 Mar 2025Severe political, humanitarian and human rights crisis in Sudan, in particular the sexual violence and child rape Adopted 575 for, 7 against, 35 abstainedPosition: For Majority line: For
13 Mar 2025Unlawful detention and sham trials of Armenian hostages, including high-ranking political representatives from Nagorno-Karabakh, by Azerbaijan Adopted 523 for, 3 against, 84 abstainedPosition: For Majority line: For
12 Mar 2025EU-Norway Agreement: modification of concessions on all the tariff-rate quotas included in EU Schedule CLXXV as a consequence of the United Kingdom's withdrawal from the European Union Consent given 525 for, 5 against, 34 abstainedPosition: For Majority line: For
12 Mar 2025Agreement between Canada and the European Union on the transfer and processing of Passenger Name Record (PNR) data Consent given 521 for, 90 against, 45 abstainedPosition: For Majority line: For
12 Mar 2025European Semester for economic policy coordination 2025 Adopted 469 for, 162 against, 54 abstainedPosition: For Majority line: For
12 Mar 2025European Semester for economic policy coordination: employment and social priorities for 2025 Adopted 351 for, 260 against, 70 abstainedPosition: Against ≠ groupMajority line: For
12 Mar 2025Continuing the unwavering EU support for Ukraine, after three years of Russia’s war of aggression Adopted 442 for, 98 against, 126 abstainedPosition: For Majority line: For
12 Mar 2025White paper on the future of European defence Adopted 419 for, 204 against, 46 abstainedPosition: For Majority line: For
12 Mar 2025The need for EU support towards a just transition and reconstruction in Syria Adopted 462 for, 76 against, 106 abstainedPosition: For Majority line: For
11 Mar 2025Establishing the Reform and Growth Facility for the Republic of Moldova Passed 499 for, 117 against, 44 abstainedPosition: For Majority line: For
11 Mar 2025Verification of credentials Adopted 643 for, 10 against, 15 abstainedPosition: For Majority line: For
11 Mar 2025European Social Fund Plus post-2027 Adopted 432 for, 155 against, 82 abstainedPosition: For Majority line: For
11 Mar 2025Assessment of the implementation of Horizon Europe in view of its interim evaluation and recommendations for the 10th Research Framework Programme Adopted 472 for, 75 against, 92 abstainedPosition: For Majority line: For
13 Feb 2025Further deterioration of the political situation in Georgia Adopted 400 for, 63 against, 81 abstainedPosition: No vote recorded Majority line: For
13 Feb 2025Escalation of violence in the eastern Democratic Republic of the Congo Adopted 443 for, 4 against, 48 abstainedPosition: No vote recorded Majority line: For
12 Feb 2025VAT: rules for the digital age Passed 589 for, 42 against, 10 abstainedPosition: No vote recorded Majority line: For
12 Feb 2025Administrative cooperation in the field of taxation Passed 608 for, 33 against, 8 abstainedPosition: No vote recorded Majority line: For
12 Feb 2025Genetically modified maize DP910521 Objection passed 477 for, 152 against, 20 abstainedPosition: No vote recorded Majority line: For
12 Feb 2025Genetically modified maize MON 95275 Objection passed 467 for, 156 against, 18 abstainedPosition: No vote recorded Majority line: For
11 Feb 2025Renewal of the Agreement on cooperation in science and technology between the European Community and Ukraine Consent given 591 for, 9 against, 9 abstainedPosition: No vote recorded Majority line: For
11 Feb 2025Conclusion, on behalf of the Union, of the Protocol (2024-2029) implementing the Fisheries Partnership Agreement between the European Community and the Republic of Cabo Verde Consent given 507 for, 76 against, 16 abstainedPosition: No vote recorded Majority line: For
11 Feb 2025Conclusion of an agreement between the European Union and the government of the People's Republic of Bangladesh on certain aspects of air services Consent given 562 for, 17 against, 3 abstainedPosition: No vote recorded Majority line: For
11 Feb 2025European Central Bank – annual report 2024 Adopted 378 for, 233 against, 26 abstainedPosition: No vote recorded Majority line: For
23 Jan 2025Systematic repression of human rights in Iran, notably the cases of Pakhshan Azizi and Wrisha Moradi, and the taking of EU citizens as hostages Adopted 556 for, 6 against, 42 abstainedPosition: For Majority line: For
23 Jan 2025Case of Boualem Sansal in Algeria Adopted 533 for, 24 against, 48 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 19 of 107 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table
Roll calls held at each sitting while in office and how many of them the member voted in.
SittingRoll callsVoted in
17 Jul 20242322
18 Jul 202411
16 Sept 202422
18 Sept 202422
19 Sept 20249291
7 Oct 202422
8 Oct 202411
9 Oct 20241818
10 Oct 202440
21 Oct 202422
22 Oct 20241010
23 Oct 2024129125
24 Oct 20241312
13 Nov 202422
14 Nov 20243636
25 Nov 202422
26 Nov 2024188
27 Nov 20241111
28 Nov 20245757
17 Dec 20241312
18 Dec 20243333
19 Dec 2024450
20 Jan 202522
21 Jan 202511
22 Jan 202522
23 Jan 20254543
10 Feb 202510
11 Feb 2025320
12 Feb 2025100
13 Feb 2025300
10 Mar 202522
11 Mar 202599
12 Mar 2025228225
13 Mar 20252424
31 Mar 202533
1 Apr 20253535
2 Apr 2025251244
3 Apr 20256259
5 May 202555
6 May 20251010
7 May 2025220216
8 May 2025103102
21 May 202520
22 May 2025530
16 Jun 202522
17 Jun 20254141
18 Jun 20259190
19 Jun 2025870
7 Jul 202511
8 Jul 20255551
9 Jul 2025134133
10 Jul 2025360
8 Sept 202511
9 Sept 202510196
10 Sept 20253433
11 Sept 20256963
6 Oct 202522
7 Oct 202555
8 Oct 20255554
9 Oct 2025650
20 Oct 202533
21 Oct 20251313
22 Oct 2025186181
23 Oct 20255552
13 Nov 2025267266
24 Nov 202533
25 Nov 20257575
26 Nov 202510085
27 Nov 20251250
15 Dec 202544
16 Dec 20256657
17 Dec 20254342
18 Dec 2025420
20 Jan 20266764
21 Jan 2026112104
22 Jan 20265854
9 Feb 202621
10 Feb 20263838
11 Feb 20261313
12 Feb 2026141138
24 Feb 20264343
9 Mar 202611
10 Mar 2026197195
11 Mar 20266058
12 Mar 20263421
25 Mar 202632
26 Mar 20266969
27 Apr 202620
28 Apr 2026225219
29 Apr 2026296284
30 Apr 20266866
18 May 202640
19 May 202630
20 May 2026960
21 May 2026980
15 Jun 202620
16 Jun 20264039
17 Jun 2026127123
18 Jun 20267775
6 Jul 202622
7 Jul 20267272
8 Jul 2026144138
9 Jul 20266762
14 Sept 202611
15 Sept 2026155150
16 Sept 20268078
17 Sept 2026124123

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within S&D

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Raphaël GLUCKSMANN S&DFrance99 % of 4 557 shared93 %
Emma RAFOWICZ S&DFrance99 % of 3 523 shared93 %
Aurore LALUCQ S&DFrance99 % of 4 157 shared93 %
Murielle LAURENT S&DFrance99 % of 4 699 shared93 %
Thomas PELLERIN-CARLIN S&DFrance99 % of 4 943 shared93 %
Eric SARGIACOMO S&DFrance98 % of 4 762 shared93 %
Nora MEBAREK S&DFrance98 % of 4 612 shared93 %
Pierre JOUVET S&DFrance98 % of 4 406 shared93 %
Claire FITA S&DFrance98 % of 4 062 shared93 %
Chloé RIDEL S&DFrance98 % of 3 432 shared93 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Catarina VIEIRA GreensNetherlands87 % of 4 580 shared83 %
Kim VAN SPARRENTAK GreensNetherlands87 % of 4 724 shared83 %
Bas EICKHOUT Former memberGreensNetherlands87 % of 3 978 shared83 %
Terry REINTKE GreensGermany87 % of 4 639 shared83 %
Sara MATTHIEU GreensBelgium87 % of 4 411 shared83 %
Tineke STRIK GreensNetherlands87 % of 4 770 shared83 %
Jana TOOM RenewEstonia87 % of 4 355 shared86 %
Yvan VEROUGSTRAETE RenewBelgium86 % of 3 864 shared86 %
Maria OHISALO GreensFinland86 % of 4 418 shared83 %
Erik MARQUARDT GreensGermany86 % of 4 784 shared83 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on DevelopmentDEVE CommitteeSubstitute19 Jul 2024now
Committee on the Environment, Climate and Food SafetyENVI CommitteeMember20 Jan 2025now
Committee on Industry, Research and EnergyITRE CommitteeSubstitute19 Jul 2024now
Committee on Public HealthSANT CommitteeMember23 Jan 2025now
Delegation to the OACPS-EU Joint Parliamentary AssemblyDACP Parliamentary assemblyVice-chair3 Oct 2024now
Delegation to the Africa-EU Parliamentary AssemblyDAFR Parliamentary assemblyVice-chair30 Sept 2024now
Intergroup on Attracting Investment to Ensure a Competitive and Sustainable European UnionIG10-03 Intergroup / working groupMember31 Jan 2025now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working groupMember27 Jan 2025now
Intergroup on Fighting against PovertyIG10-12 Intergroup / working groupMember20 Feb 2026now
Intergroup on the Future of Education and Skills for a Competitive EuropeIG10-14 Intergroup / working groupMember29 Jan 2025now

Show all 20 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
Establishing a framework of measures for the acceleration of industrial capacity and decarbonisation in strategic sectors and amending Regulations (EU) 2018/1724, (EU) 2024/1735 and (EU) 2024/3110Shadow rapporteur for an opinionENVI18 Jun 2026
AACP delegation in Abidjan (May 2026)Official delegationDAFR10 Mar 2026
European Chemicals Agency and amending Regulations (EC) No 1907/2006, (EU) No 528/2012, (EU) No 649/2012 and (EU) 2019/1021RapporteurENVI8 Dec 2025
Gender inequalities in health, specifically as regards gender-specific conditionsShadow rapporteur for an opinionSANT13 Nov 2025
Union Civil Protection Mechanism and Union support for health emergency preparedness and response, and repealing Decision No 1313/2013/EU (Union Civil Protection Mechanism)Shadow rapporteurSANT13 Nov 2025
Union Civil Protection Mechanism and Union support for health emergency preparedness and response, and repealing Decision No 1313/2013/EU (Union Civil Protection Mechanism)Shadow rapporteurSANT29 Oct 2025
Ensuring faster registration and uptake of biological control agentsShadow rapporteurENVI8 Jul 2025
No dossier namedOfficial delegationENVI13 May 2025
the Plants obtained by certain new genomic techniques and their food and feed, and amending Regulation (EU) 2017/625Shadow rapporteurENVI25 Nov 2024
No dossier namedOpinion rapporteur · 2 declarationsENVI25 Nov 2024

Show all 14 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

48 contributions recorded; 15 on behalf of their group; 61 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
17 Sept 2026Strengthening global health resilience in partner countries (debate) on behalf of S&DSpeech · 1 minRead
17 Jun 2026Plants obtained by certain new genomic techniques and their food and feed (A10-0175/2026 - Jessica Polfjärd) (vote) on behalf of S&DSpeech · 1 minRead
29 Apr 2026European Chemicals Agency and amending regulations (A10-0093/2026 - Christophe Clergeau) (vote) SpeechRead
29 Apr 2026European Chemicals Agency and amending regulations (A10-0093/2026 - Christophe Clergeau) (vote) Speech · 1 minRead
25 Mar 2026Implementation of the Urban Wastewater Treatment Directive (UWWTD) and risks to the security of supply of medicines (debate) Speech · 2 minRead
9 Mar 2026Upcoming European Research Area (ERA) Act (debate) Speech · 1 minRead
9 Mar 2026Order of business Speech · 1 minRead
10 Feb 2026Extreme weather events in particular in Portugal, southern Italy, Malta and Greece: European response in strengthening readiness, preparedness and solidarity mechanisms (debate) on behalf of S&DSpeech · 3 minRead
9 Feb 2026World Cancer Day (debate) Speech · 1 minRead
9 Feb 2026World Cancer Day (debate) Speech · 1 minRead
20 Jan 2026Presentation of the programme of activities of the Cyprus Presidency (continuation of debate) Speech · 1 minRead
19 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest (debate) SpeechRead
19 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest (debate) on behalf of S&DSpeech · 1 minRead
16 Dec 2025Presentation of the EU Cardiovascular Health Plan (debate) on behalf of S&DSpeech · 1 minRead
24 Nov 2025Ensuring faster registration and uptake of biological control agents (short presentation) Speech · 1 minRead
21 Oct 2025Commission Work Programme 2026 (debate) Speech · 1 minRead
20 Oct 2025Chemicals (joint debate) on behalf of S&DSpeech · 2 minRead
7 Oct 2025Common agricultural policy (joint debate) Speech · 2 minRead
11 Sept 2025Summer of heatwaves in the EU: addressing the causes and providing adequate housing and health policies to address record-breaking temperatures (debate) Speech · 1 minRead
11 Sept 2025Summer of heatwaves in the EU: addressing the causes and providing adequate housing and health policies to address record-breaking temperatures (debate) on behalf of S&DSpeech · 1 minRead
9 Jul 2025Presentation of the Stockpiling Strategies - strengthening response capacities for a changing risk and threat landscape (debate) on behalf of S&DSpeech · 1 minRead
8 Jul 2025Presentation of the Chemicals Package (debate) on behalf of S&DSpeech · 2 minRead
17 Jun 2025European Ocean Pact (debate) Speech · 1 minRead
17 Jun 2025European Ocean Pact (debate) on behalf of S&DSpeech · 2 minRead
8 May 2025EU action on treating and preventing diseases such as cancer, cardiovascular neurological diseases and measles (debate) Speech · 2 minRead
6 May 2025The European Water Resilience Strategy (debate) on behalf of S&DSpeech · 1 minRead
6 May 2025Discharge 2023 (joint debate) Speech · 1 minRead
2 Apr 2025European oceans pact (debate) SpeechRead
2 Apr 2025European oceans pact (debate) on behalf of S&DSpeech · 3 minRead
1 Apr 2025EU Preparedness Union Strategy (debate) Speech · 1 minRead
31 Mar 2025Re-attribution of scientific and technical tasks and improving cooperation among Union agencies in the area of chemicals (short presentation) Speech · 1 minRead
31 Mar 2025Common data platform on chemicals, establishing a monitoring and outlook framework for chemicals (short presentation) Speech · 1 minRead
13 Mar 2025A Vision for Agriculture and Food (debate) Speech · 1 minRead
12 Mar 2025100 days of the new Commission – Delivering on defence, competitiveness, simplification and migration as our priorities (topical debate) Speech · 1 minRead
11 Mar 2025Presentation of the proposal on Critical Medicines Act (CMA) (debate) on behalf of S&DSpeech · 1 minRead
22 Jan 2025EU financing through the LIFE programme of entities lobbying EU institutions and the need for transparency (debate) Speech · 1 minRead
22 Jan 2025EU financing through the LIFE programme of entities lobbying EU institutions and the need for transparency (debate) Speech · 1 minRead
22 Jan 2025Failure of the negotiations in Busan for a UN plastic treaty and the urgent need to tackle plastic pollution at international and Union level (debate) on behalf of S&DSpeech · 2 minRead
22 Jan 2025Addressing EU demographic challenges: towards the implementation of the 2023 Demography Toolbox (debate) SpeechRead
22 Jan 2025Addressing EU demographic challenges: towards the implementation of the 2023 Demography Toolbox (debate) Speech · 1 minRead

Questions and motions, 54

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
11 Sept 2026MOTION FOR A RESOLUTION on the draft Commission regulation amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, etofenprox, fenpropidin, flupyradifurone, hexythiazox, imazalil, spinosad and tebufenozide in or on certain products B-10-2026-0392Motion for a resolutionwith 3 co-authors—
10 Sept 2026EU exports of banned pesticides E-10-2026-003605Written questionwith 35 co-authorsNot yet answered
14 Jul 2026Preserving EU capacities to produce paper pulp and cellulose fibres – state of affairs at Fibre Excellence P-10-2026-002901Priority written questionwith 12 co-authors12 Aug 2026
8 Jul 2026European funds allocated to fighting period poverty E-10-2026-002822Written questionwith 36 co-authorsNot yet answered
3 Jul 2026Follow-up to the European Citizens’ Panel on Preparedness E-10-2026-002778Written questionwith 9 co-authors21 Aug 2026
1 Jul 2026PROPOSAL FOR A DECISION requesting the Authority for European Political Parties and European Political Foundations to verify whether Europe of Sovereign Nations Party complies with the conditions laid down in Article 3(1), points (d) and (e), of Regulation (EU, Euratom) 2025/2445 B-10-2026-0338Motion for a resolutionwith 246 co-authors—
30 Jun 2026Follow-up to question for written answer E-001083/2025 on menstrual products: transparency and health risks E-10-2026-002698Written questionwith 43 co-authors18 Sept 2026
29 Jun 2026Allowing advanced practice nurses to renew or adapt treatments E-10-2026-002671Written question21 Aug 2026
19 Jun 2026Ban the butt: it is time to stub out cigarette filters E-10-2026-002547Written questionwith 9 co-authors3 Sept 2026
23 Apr 2026Risks hanging over the European steel industry and use of public funding by ArcelorMittal E-10-2026-001682Written questionwith 12 co-authors8 Jun 2026

Show all 54 questions and motions

Amendments tabled in committee, 95

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792138 CJ6422
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792139 CJ6432
23 Jul 2026Proposal for a Regulation of the European Parliament and of the Council establishing a framework of measures for the acceleration of industrial capacity and decarbonisation in strategic sectors and amending Regulations (EU) 2018/1724, (EU) 2024/1735 and (EU) 2024/3110 ENVI-AM-791125 ENVI71
23 Jul 2026Proposal for a Regulation of the European Parliament and of the Council establishing a framework of measures for the acceleration of industrial capacity and decarbonisation in strategic sectors and amending Regulations (EU) 2018/1724, (EU) 2024/1735 and (EU) 2024/3110 ENVI-AM-791124 ENVI50
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934 CJ531
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790005 CJ533
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936 CJ533
23 Jun 2026on the proposal for a regulation of the European Parliament and of the Council establishing the European Fund for economic, social and territorial cohesion, agriculture and rural, fisheries and maritime, prosperity and security for the period 2028-2034 and amending Regulation (EU) 2023/955 and Regulation (EU, Euratom) 2024/2509 CJ71-AM-790094 CJ712
23 Jun 2026on the proposal for a regulation of the European Parliament and of the Council establishing the European Fund for economic, social and territorial cohesion, agriculture and rural, fisheries and maritime, prosperity and security for the period 2028-2034 and amending Regulation (EU) 2023/955 and Regulation (EU, Euratom) 2024/2509 CJ71-AM-790098 CJ712
23 Jun 2026on the proposal for a regulation of the European Parliament and of the Council establishing the European Fund for economic, social and territorial cohesion, agriculture and rural, fisheries and maritime, prosperity and security for the period 2028-2034 and amending Regulation (EU) 2023/955 and Regulation (EU, Euratom) 2024/2509 CJ71-AM-790103 CJ712

Show all 95 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation France National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Christophe CLERGEAU”. Member record. memberId 245018. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/245018?page=11&speeches=all&vscope=final (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/245018. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/245018?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-245018,
  author = {{EU Parl Watch Research}},
  title = {{Christophe CLERGEAU}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/245018?page=11&speeches=all&vscope=final}},
  url = {https://news.eu-parl.st-solutions.dev/members/245018?page=11&speeches=all&vscope=final},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 245018. Official source: https://www.europarl.europa.eu/meps/en/245018. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}